Detalhe da pesquisa
1.
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
N Engl J Med
; 377(16): 1513-1524, 2017 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844193
2.
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting.
Clin Cardiol
; 39(10): 555-564, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565018
3.
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.
Lancet Diabetes Endocrinol
; 2(5): 369-84, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24795251